astragaloside a has been researched along with Allergic Encephalomyelitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, M; Kumar, G; Liu, C; Ma, C; Meng, T; Mu, B; Song, L; Yan, Y; Yu, J | 1 |
| Han, X; Hu, Z; Huang, F; Shi, H; Wu, H; Wu, X; Xing, F; Yang, L; Yuan, J; Zhang, T | 1 |
| Huang, F; Lan, Y; Li, H; Liu, M; Shi, H; Wu, H; Wu, X; Yang, L; Zhang, B; Zhang, W | 1 |
| Du, M; Gao, Y; He, Y; Liu, H; Wang, H; Wang, Z; Wu, X | 1 |
| Du, M; He, YX; Huang, F; Lan, YY; Liu, HS; Peterson, KE; Shi, HL; Wang, ZT; Woods, T; Wu, H; Wu, XJ; Zhang, BB | 1 |
5 other study(ies) available for astragaloside a and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Astragaloside IV inhibits experimental autoimmune encephalomyelitis by modulating the polarization of both microglia/macrophages and astrocytes.
Topics: Animals; Astrocytes; Encephalomyelitis, Autoimmune, Experimental; Humans; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Saponins | 2023 |
Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells.
Topics: Animals; Coculture Techniques; Cytokines; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Female; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Saponins; Severity of Illness Index; Triterpenes | 2020 |
P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Cell Line; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Female; Mice; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Quinolines; Saponins; Substrate Specificity; Triterpenes | 2019 |
Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels.
Topics: Animals; Antioxidants; Apoptosis Regulatory Proteins; CD11b Antigen; Cell Line; Cytokines; Demyelinating Diseases; Disease Models, Animal; Disease Progression; Drugs, Chinese Herbal; Encephalomyelitis, Autoimmune, Experimental; Female; Forkhead Transcription Factors; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Inflammation; Mice; Multiple Sclerosis; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Saponins; T-Box Domain Proteins; Th1 Cells; Th17 Cells; Triterpenes | 2013 |
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Binding, Competitive; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation Mediators; Ligands; Lipopolysaccharides; Mice; Microglia; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; NF-kappa B; Protein Binding; Receptors, Glucocorticoid; Saponins; Signal Transduction; Toll-Like Receptors; Triterpenes | 2016 |